166 related articles for article (PubMed ID: 30969443)
1. Serological investigation of bullous scabies and review of the published work.
Kokubu H; Takahashi T; Tateishi C; Tsuruta D; Hashimoto T; Tanaka T; Fujimoto N
J Dermatol; 2019 Sep; 46(9):e324-e325. PubMed ID: 30969443
[No Abstract] [Full Text] [Related]
2. Elevated levels of circulating immunoglobulin E autoantibodies against BP180 and BP230 in an intractable case of bullous pemphigoid.
Akasaka E; Hagiwara C; Takiyoshi N; Aizu T; Nakano H; Sawamura D; Ota T
J Dermatol Sci; 2016 Oct; 84(1):110-113. PubMed ID: 27492811
[No Abstract] [Full Text] [Related]
3. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
Huang MX; Li ZS; Luo DQ; Lin Q
G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
[No Abstract] [Full Text] [Related]
4. A case of bullous pemphigoid with IgG antibodies against LAD-1, but not BP180 NC16a domain or BP230.
Miyashita K; Iioka H; Miyagawa F; Ishii N; Hashimoto T; Asada H
Eur J Dermatol; 2018 Apr; 28(2):248-250. PubMed ID: 29378676
[No Abstract] [Full Text] [Related]
5. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
[No Abstract] [Full Text] [Related]
6. Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.
Gutjahr A; Heck F; Emtenani S; Hammers AK; Hundt JE; Muck P; Siegel DL; Schmidt E; Stanley JR; Zillikens D; Hammers CM
Br J Dermatol; 2019 Sep; 181(3):593-594. PubMed ID: 31124130
[No Abstract] [Full Text] [Related]
7. A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
Schauer F; Kern JS; Virtic O; Technau-Hafsi K; Meiss F; Thoma K; Athanasiou I; Sitaru C; Di Zenzo G; Izumi K; Nishie W; Shimizu H; Bruckner-Tuderman L; Kiritsi D
Br J Dermatol; 2019 Jan; 180(1):231-232. PubMed ID: 30188568
[No Abstract] [Full Text] [Related]
8. Sensitivities and utility of non-invasive serological tests in the diagnosis of bullous pemphigoid.
Yew YW; Tey HL
Int J Dermatol; 2016 Sep; 55(9):e510-1. PubMed ID: 27028937
[No Abstract] [Full Text] [Related]
9. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
[No Abstract] [Full Text] [Related]
10. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
[TBL] [Abstract][Full Text] [Related]
11. Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.
Ashida H; Hamada T; Hosokawa Y; Hashimoto T; Nishie W; Ishii N; Nakama T; Kanno T; Ikeda M
Acta Derm Venereol; 2019 Nov; 99(12):1172-1173. PubMed ID: 31449311
[No Abstract] [Full Text] [Related]
12. Erythema Multiforme-Like Bullous Pemphigoid.
Imbernón-Moya A; Aguilar A; Burgos F; Gallego MÁ
Actas Dermosifiliogr; 2016 Oct; 107(8):689-91. PubMed ID: 27048923
[No Abstract] [Full Text] [Related]
13. A dilemma: bullous-pemphigoid-like eruption in scabies or scabies-induced bullous pemphigoid.
Balighi K; Robati RM; Hejazi N
Dermatol Online J; 2006 May; 12(4):13. PubMed ID: 17083868
[TBL] [Abstract][Full Text] [Related]
14. Positive house dust mite skin test in a nonatopic patient with scabies.
Bajoghli AA; Bajoghli M; Adler S
Ann Allergy Asthma Immunol; 2014 Dec; 113(6):667. PubMed ID: 25466803
[No Abstract] [Full Text] [Related]
15. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
Julio T; Vernal S; Turatti A; Roselino AM
Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
[No Abstract] [Full Text] [Related]
16. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
[TBL] [Abstract][Full Text] [Related]
17. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
18. Brunsting-Perry type pemphigoid with IgG autoantibodies to laminin-332, BP230 and desmoplakins I/II.
Fukuda S; Tsuruta D; Uchiyama M; Mitsuhashi Y; Kobayashi H; Ishikawa T; Ohyama B; Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Br J Dermatol; 2011 Aug; 165(2):433-5. PubMed ID: 21457206
[No Abstract] [Full Text] [Related]
19. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
20. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332.
Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M
J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181
[No Abstract] [Full Text] [Related]
[Next] [New Search]